Bhangoo RS, DeWees TA, Thorpe CS, Petersen M, et al. Updated Toxicity and Quality-of-Life Outcomes From a Randomized Phase III Trial of Extreme Hypofractionated vs. Standard Fractionated Proton Therapy for Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701049